Article, 2024

MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations

TRANSLATIONAL LUNG CANCER RESEARCH, ISSN 2218-6751, Volume 13, 4, Pages 940-946, 10.21037/tlcr-24-98

Contributors

Jorgensen, Jan Trost (Corresponding author) [1] Urbanska, Edyta Maria [2] [3] Mollerup, Jens [4]

Affiliations

  1. [1] Dx Rx Inst, Med Sci, Baunevaenget 76, DK-3480 Fredensborg, Denmark
    2. [NORA names: Other Companies; Private Research; Denmark; Europe, EU; Nordic; OECD];
  2. [2] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark
    3. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  3. [3] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark
    4. [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
  4. [4] Agilent Technol Denmark ApS, Pathol Div, Glostrup, Denmark
    5. [NORA names: Other Companies; Private Research; Denmark; Europe, EU; Nordic; OECD]

Keywords

MET exon 14-skipping mutations ( MET ex14), Non-small-cell lung cancer (NSCLC);, capmatinib, companion diagnostics, tepotinib

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+